← All sessions

MedTech Leading Voice · 19 Aug 2026

When Enrollment Stops: Diagnosing a Study That's Already Gone Wrong

Daniela and Matteo Mosso use four rescue studies to show why enrolment stalls and what actually restarts it.

Plays from YouTube when you press play. Cookie settings

What the session covered

In this session Daniela and Matteo Mosso worked through four real studies where enrolment had stalled or stopped, and explained how each was rescued. The first was a randomised post-market study for a legacy device facing an MDR deadline: four sites had enrolled two patients in three months. Marketing had chosen sites unfamiliar with trials, and a three-day exclusion window blocked recruitment. The team amended the protocol, added properly selected sites and reached 62 patients. The second, an IVD colorectal cancer study, had about 400 patients whose data sat in source documents and had not been entered into the CRF at one Spanish site. Two CRO changes had left monitoring and data transfer in disarray. Keeping the existing CRF, fixing the data flow and deploying two CRAs in parallel cleared the backlog and enrolment passed 1,300. The third, a US FDA study run in-house by an IVD company, had no clear ownership between European and US teams and began before statistical agreement with the FDA. A gap analysis led to a rewritten protocol, 18 sites and about 2,500 patients. The fourth, an implantable cardiovascular device, had seven active sites and no patients because investigators were reluctant about open heart surgery. Site visits, peer advocacy and animal training led to 45 patients. The common thread: sites are partners, not vendors; find the root cause early; and bring in outside eyes. They put delay costs at €1,000 to €7,000 per site per day.

Figures

Figures the speakers cited

1,000–7,000euro per site per day estimated additional operational cost from enrollment delay
2patients enrolled in the first case after three months across four sites
62patients enrolled in the first case after remediation
400patient records sitting in source documents without CRF entry in the second case
1,300patients completed in the second case
18sites scaled up to in the third case, from eight
2,500patients enrolled in the third case
7active sites with zero patients enrolled in the fourth case
45patients enrolled in the fourth case

Source: Daniela Carrera

Chapters

Jump to a moment

  1. Introduction, housekeeping, and session framing
  2. Why enrollment is the biggest uncertainty and the cost of delay
  3. Case one: MDR PMCF study with four sites and two patients
  4. Case two: IVD colorectal study, CRO transition, and CRF backlog
  5. Case three: FDA study gap analysis and management reset
  6. Q&A on pre-sub meetings, data entry, and patient selection
  7. Case four: implantable cardiovascular device with zero enrollment
  8. Final lessons on sites, root cause, and outside perspective

Times run from the start of the recording.

Take these with you

Six checks

Treat sites as partnersSelect sites carefully, explain study workload and requirements, and support them after commitment.
Find the root cause firstUse site feedback and data to diagnose why enrollment stopped before choosing a protocol or site fix.
Act in parallelWhen enrollment is critical, implement multiple corrective actions at the same time rather than step by step.
Check site readiness and motivationConfirm that investigators understand the protocol and have resources before relying on them for enrollment.
Separate entry from monitoringIf a CRO supports data entry, define roles and procedures so data entry and monitoring are not done by the same people.
Bring in senior and outside voicesUse senior sponsor staff, peer investigators, and external reviewers when site teams are blocked or too close to the problem.

Full recording

58:10

Plays from YouTube when you press play. Cookie settings

How to cite this session

mosso, m., Karrer, D. (2026, August 19). When Enrollment Stops: Diagnosing a Study That's Already Gone Wrong [Webinar]. MedTech Leading Voice, MedTech Leading Voice. medtechleadingvoice.com/watch/2026-08-19-when-enrollment-stops-diagnosing-a-study-that-s-already-gone-wrong

Sponsored by Donawa Lifescience
Talk to the speakers about When Enrollment Stops: Diagnosing a Study That's Already Gone Wrong
Tell us what you're working on and the Donawa Lifescience team will get back to you.

Earlier sessions

13 Nov 2026Architecting a Claims Support System 6 Nov 2026Methodological Quality and Scientific Validity Under the MDR 30 Oct 2026AI Pre-Submission Review Under the MDR

Latest issues

Issue 190FDA and the Future of Generative AI Medical Devices Issue 189MDR and IVDR Evidence Requirements in Transition Issue 188Industry Groups Back a Single Regulatory Pathway for AI-Enabled Medical Devices